FDA OKs subcutaneous vedolizumab for UC maintenance therapy

Press/Media

Period	29 Sep 2023

Media coverage

Title	FDA OKs subcutaneous vedolizumab for UC maintenance therapy
Media name/outlet	Clinician Reviews
Country/Territory	United States
Date	29/09/23
URL	ct.moreover.com/?a=51934722768&p=1gw&v=1&x=WCgwM1BEwkEXYrscrlfgZA
Persons	Bruce E. Sands